Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
-
- Stephen Salloway
- Warren Alpert Medical School, Brown University, Providence, Rhode Island
-
- Spyros Chalkias
- Biogen, Cambridge, Massachusetts
-
- Frederik Barkhof
- Institutes of Healthcare Engineering and Neurology, University College London, London, United Kingdom
-
- Patrick Burkett
- Biogen, Cambridge, Massachusetts
-
- Jerome Barakos
- California Pacific Medical Center, San Francisco
-
- Derk Purcell
- California Pacific Medical Center, San Francisco
-
- Joyce Suhy
- Bioclinica, Newark, California
-
- Fiona Forrestal
- Biogen, Cambridge, Massachusetts
-
- Ying Tian
- Biogen, Cambridge, Massachusetts
-
- Kimberly Umans
- Biogen, Cambridge, Massachusetts
-
- Guanfang Wang
- Cytel Inc, Waltham, Massachusetts
-
- Priya Singhal
- Biogen, Cambridge, Massachusetts
-
- Samantha Budd Haeberlein
- Biogen, Cambridge, Massachusetts
-
- Karen Smirnakis
- Biogen, Cambridge, Massachusetts
収録刊行物
-
- JAMA Neurology
-
JAMA Neurology 79 (1), 13-, 2022-01-01
American Medical Association (AMA)
